Longliv invests $5m in microbiome co DayTwo

11:51 EDT 6 Oct 2019 | Globes

The Israeli company has developed a microbiome human discovery platform that offers a glycemic control solution for people with type II diabetes.

Original Article: Longliv invests $5m in microbiome co DayTwo


More From BioPortfolio on "Longliv invests $5m in microbiome co DayTwo"

Quick Search

Relevant Topic

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...